Press

H7N9 avian influenza in humans: sex differences in disease outcome

Monday, 14. November 2022

New research shows that H7N9 infections attack the hormonal axis of males but not females

PROVIREX ESTABLISHES THERAPY HUB FOR THE CURE OF HIV IN HAMBURG'S SCIENCE CITY BAHRENFELD

Thursday, 27. October 2022

Further procedure of the LIV spin-off PROVIREX is presented

SARS-CoV-2: Antiviral treatment promotes emergence of new variants

Wednesday, 17. August 2022

Study published in Cell Reports Medicine

Institute renaming: HPI becomes LIV - Leibniz Institute of Virology

Monday, 09. May 2022

Relaunch with new name and logo

New Junior Research Group "Genomics of Retroviral Infections"

Monday, 02. May 2022

Dr. Ulrike Lange complements the research spectrum of the institute with her junior research group starting in May 2022

Human Cytomegalovirus: Phase-separated compartments support replication

Wednesday, 09. March 2022

Results published in Cell Reports

Surpassing the genetic code: Influence of epigenetics on infections and the immune system

Monday, 24. January 2022

International Symposium of the Leibniz Center Infection